Related Experiment Video
Updated: Feb 16, 2026

Quantitative Autonomic Testing
Published on: July 19, 2011
Autoimmune autonomic neuropathies: time to look beyond autoimmune autonomic ganglionopathy
1Department of Neurology, Stanford Medical Center, Stanford Neuroscience Health Center, 213 Quarry Road, 2nd Floor, Palo Alto, CA, 94304, USA. muppidis@stanford.edu.
No abstract available in PubMed .
More Related Videos
05:44A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
Published on: December 9, 2022
04:47Autonomously Bioluminescent Mammalian Cells for Continuous and Real-time Monitoring of Cytotoxicity
Published on: October 28, 2013
Related Concept Videos
Autonomic Nervous System
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
Autonomic Nervous System: Overview
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs Acting on Autonomic Ganglia: Blockers